Chester County News and Community Website
EXTON, PA — ProRx Pharma said it expanded its operations, tripled production capacity, and entered new markets to meet growing demand for compounded medications.
Inside ProRx’s Rapid Expansion: Production Triples, Footprint Grows Read More
WASHINGTON, D.C. — Federal regulators are exploring whether testosterone replacement therapy could be expanded to treat low libido in certain men, a move that could broaden access to treatment for …
FDA Signals Potential Expansion of Testosterone Therapy Use Read More
WASHINGTON, D.C. — Federal health officials announced a new partnership with leading urology organizations aimed at expanding awareness and use of a treatment that researchers say can help prevent recurring …
New Federal Partnership Targets Overlooked Menopause Health Risks Read More
WASHINGTON, D.C. — The long-standing FDA warnings on hormone replacement therapy for menopause are being dismantled, as the U.S. Department of Health and Human Services on Monday announced the removal …
HHS Overhauls Menopause Drug Warnings as FDA Unveils Major Women’s Health Shift Read More EXTON, PA — ProRx Pharma launched a patented Liquid Nanoemulsion Delivery System that offers a needle-free alternative to injectable medications and, according to the company, positions ProRx as the only …
ProRx Bets on Needle-Free Nanoemulsions—Will Faster Absorption Win? Read More